| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 90999 |
Unlisted dialysis procedure, inpatient or outpatient |
141,349 |
11,232 |
$8.80M |
| 90945 |
|
86,917 |
2,558 |
$1.65M |
| Q4081 |
Injection, epoetin alfa, 100 units (for esrd on dialysis) |
108,951 |
7,901 |
$1.09M |
| J0887 |
Injection, epoetin beta, 1 microgram, (for esrd on dialysis) |
2,405 |
1,460 |
$1.07M |
| J1756 |
Injection, iron sucrose, 1 mg |
30,195 |
8,152 |
$246K |
| J0604 |
Cinacalcet, oral, 1 mg, (for esrd on dialysis) |
3,829 |
1,268 |
$11K |
| A4657 |
Syringe, with or without needle, each |
61,818 |
10,057 |
$10K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
423 |
194 |
$3K |
| J1270 |
Injection, doxercalciferol, 1 mcg |
58,517 |
4,543 |
$297.31 |
| 83970 |
|
3,536 |
3,061 |
$113.42 |
| G0499 |
Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result |
1,651 |
1,131 |
$56.54 |
| 82108 |
|
1,293 |
1,142 |
$22.49 |
| 82728 |
|
3,366 |
2,884 |
$15.97 |
| 85041 |
|
4,282 |
3,768 |
$9.20 |
| 85048 |
|
4,260 |
3,748 |
$7.79 |
| 83540 |
|
3,356 |
2,882 |
$7.58 |
| 83550 |
|
2,951 |
2,518 |
$2.33 |
| G0008 |
Administration of influenza virus vaccine |
639 |
556 |
$0.00 |
| 84540 |
|
313 |
221 |
$0.00 |
| G0010 |
Administration of hepatitis b vaccine |
579 |
473 |
$0.00 |
| 90747 |
|
683 |
547 |
$0.00 |
| 0011A |
|
60 |
41 |
$0.00 |
| 90674 |
|
367 |
306 |
$0.00 |
| 0064A |
|
70 |
44 |
$0.00 |
| 0012A |
|
49 |
36 |
$0.00 |
| G0009 |
Administration of pneumococcal vaccine |
13 |
12 |
$0.00 |
| 82570 |
|
746 |
275 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
48,180 |
3,375 |
$0.00 |
| 90662 |
|
235 |
208 |
$0.00 |
| 90661 |
|
21 |
21 |
$0.00 |
| 0124A |
|
35 |
28 |
$0.00 |